Literature DB >> 10405413

Coinfection with multiple tick-borne pathogens in a Walker Hound kennel in North Carolina.

S K Kordick1, E B Breitschwerdt, B C Hegarty, K L Southwick, C M Colitz, S I Hancock, J M Bradley, R Rumbough, J T Mcpherson, J N MacCormack.   

Abstract

Both dogs and humans can be coinfected with various Ehrlichia, Bartonella, Rickettsia, and Babesia species. We investigated a kennel of sick Walker Hounds and their owners in southeastern North Carolina for evidence of tick-borne infections and associated risk factors. A high degree of coinfection was documented in the dog population. Of the 27 dogs, 26 were seroreactive to an Ehrlichia sp., 16 to Babesia canis, and 25 to Bartonella vinsonii, and 22 seroconverted to Rickettsia rickettsii antigens. According to PCR results, 15 dogs were infected with Ehrlichia canis, 9 with Ehrlichia chaffeensis, 8 with Ehrlichia ewingii, 3 with Ehrlichia equi, 9 with Ehrlichia platys, 20 with a Rickettsia species, 16 with a Bartonella species, and 7 with B. canis. The detection of DNA from any Ehrlichia species was associated with clinical illness and with concurrent B. canis infection (by PCR). Both E. canis and an uncharacterized Rickettsia species appeared to result in chronic or recurrent infection. Death in the dog population was associated with living in a dirt lot rather than the concrete kennel. Of 23 people on whom serologic testing was conducted, eight were seroreactive to Bartonella henselae, one to E. chaffeensis, and one to R. rickettsii antigen; however, none had clinical or hematologic abnormalities consistent with illness caused by these organisms. We conclude that kennel dogs with heavy tick exposure can be infected at a high rate with multiple, potentially zoonotic, tick-borne pathogens. In addition, our findings further illustrate the utility of PCR for documenting coinfection with tick-transmitted pathogens.

Entities:  

Mesh:

Year:  1999        PMID: 10405413      PMCID: PMC85300     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Granulocytic ehrlichiosis in dogs from North Carolina and Virginia.

Authors:  E E Goldman; E B Breitschwerdt; C B Grindem; B C Hegarty; J J Walls; J S Dumler
Journal:  J Vet Intern Med       Date:  1998 Mar-Apr       Impact factor: 3.333

2.  Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.

Authors:  D L Kordick; T T Brown; K Shin; E B Breitschwerdt
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Manifestations of babesiosis, ehrlichiosis, and combined infections in the dog.

Authors:  S A Ewing; R G Buckner
Journal:  Am J Vet Res       Date:  1965-07       Impact factor: 1.156

4.  Seroprevalence of Ehrlichia canis, Ehrlichia equi, and Ehrlichia risticii in sick dogs from North Carolina and Virginia.

Authors:  J Suksawat; B C Hegarty; E B Breitschwerdt
Journal:  J Vet Intern Med       Date:  2000 Jan-Feb       Impact factor: 3.333

5.  Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Papich; B C Hegarty; B Gilger; S I Hancock; M G Davidson
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

7.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Cell-mediated and humoral immune responses of German Shepherd Dogs and Beagles to experimental infection with Ehrlichia canis.

Authors:  M Nyindo; D L Huxsoll; M Ristic; I Kakoma; J L Brown; C A Carson; E H Stephenson
Journal:  Am J Vet Res       Date:  1980-02       Impact factor: 1.156

9.  Persistent parasitemia after acute babesiosis.

Authors:  P J Krause; A Spielman; S R Telford; V K Sikand; K McKay; D Christianson; R J Pollack; P Brassard; J Magera; R Ryan; D H Persing
Journal:  N Engl J Med       Date:  1998-07-16       Impact factor: 91.245

10.  Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report.

Authors:  D J Sexton; G R Corey; C Carpenter; L Q Kong; T Gandhi; E Breitschwerdt; B Hegarty; S M Chen; H M Feng; X J Yu; J Olano; D H Walker; S J Dumler
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more
  89 in total

1.  Seroprevalence and risk factors associated with Ehrlichia canis, Anaplasma spp., Borrelia burgdorferi sensu lato, and D. immitis in hunting dogs from southern Italy.

Authors:  Diego Piantedosi; Benedetto Neola; Nicola D'Alessio; Francesca Di Prisco; Mario Santoro; Laura Pacifico; Giovanni Sgroi; Luigi Auletta; Jesse Buch; Ramaswamy Chandrashekar; Edward B Breitschwerdt; Vincenzo Veneziano
Journal:  Parasitol Res       Date:  2017-08-04       Impact factor: 2.289

2.  Determination of the nucleotide sequences of heat shock operon groESL and the citrate synthase gene (gltA) of Anaplasma (Ehrlichia) platys for phylogenetic and diagnostic studies.

Authors:  Hisashi Inokuma; Kaori Fujii; Masaru Okuda; Takafumi Onishi; Jean-Pierre Beaufils; Didier Raoult; Philippe Brouqui
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Bartonella species as a potential cause of epistaxis in dogs.

Authors:  Edward B Breitschwerdt; Barbara C Hegarty; Ricardo Maggi; Eleanor Hawkins; Page Dyer
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States.

Authors:  Alberto Alberti; Rosanna Zobba; Bernardo Chessa; Maria Filippa Addis; Olivier Sparagano; Maria Luisa Pinna Parpaglia; Tiziana Cubeddu; Gianpaolo Pintori; Marco Pittau
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

5.  The low seroprevalence of tick-transmitted agents of disease in dogs from southern Ontario and Quebec.

Authors:  Anthony T Gary; Jinelle A Webb; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  Can Vet J       Date:  2006-12       Impact factor: 1.008

6.  Coinfection with multiple tick-borne and intestinal parasites in a 6-week-old dog.

Authors:  Arnon Gal; Shimon Harrus; Itamar Arcoh; Eran Lavy; Itzhak Aizenberg; Yael Mekuzas-Yisaschar; Gad Baneth
Journal:  Can Vet J       Date:  2007-06       Impact factor: 1.008

7.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Detection of Anaplasmataceae agents and co-infection with other tick-borne protozoa in dogs and Rhipicephalus sanguineus sensu lato ticks.

Authors:  Van Lun Low; Batah Kunalan Prakash; Yvonne Ai-Lian Lim; Tiong Kai Tan; Wei Yin Vinnie-Siow; Mohd Sofian-Azirun; Sazaly AbuBakar
Journal:  Exp Appl Acarol       Date:  2018-08-02       Impact factor: 2.132

9.  Comparison of serological detection methods for diagnosis of Ehrlichia canis infections in dogs.

Authors:  Myriam Bélanger; Heather L Sorenson; Michelle K France; Michael V Bowie; Anthony F Barbet; Edward B Breitschwerdt; A Rick Alleman
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Flinders Island spotted fever rickettsioses caused by "marmionii" strain of Rickettsia honei, Eastern Australia.

Authors:  Nathan B Unsworth; John Stenos; Stephen R Graves; Antony G Faa; G Erika Cox; John R Dyer; Craig S Boutlis; Amanda M Lane; Matthew D Shaw; Jennifer Robson; Michael D Nissen
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.